Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02844465 · ClinicalTrials.gov registry record · NA
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT02844465 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 167 participants.
The verdict
NCT02844465, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).
Interventions
- DEVICE Visualase MRI-Guided Laser Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2016-12 |
| Est. Completion | 2023-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02844465
The ClinicalTrials.gov registry entry for NCT02844465 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Visualase MRI-Guided Laser Ablation is the first listed.
NCT02844465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02844465 about?
NCT02844465 is a clinical study titled "Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)". The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).
What is the current status of trial NCT02844465?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2016-12. Estimated completion is 2023-12-11.
What interventions are being tested in trial NCT02844465?
The interventions under investigation include: Visualase MRI-Guided Laser Ablation (DEVICE).
Who is sponsoring clinical trial NCT02844465?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.